OPSM Australia & New Zealand Webinars targeted at Optometrists on Moderate to Severe Dry Eye Disease
Date: 26/10/2021 (AEDT)
Venue: Live Webinar - Zoom
Provider: Andrew Cooney - Novartis Pharmaceuticals Australia Pty Ltd
Contact: Andrew Cooney, [E] andrew.cooney@novartis.com, [P] 0437 797 667
To Register: https://www.medhub.com.au/en/node/10976?hash=207fedf4e7a4d52861893e228f3508b37218e366088ea123751a4cb8a0393c3e
Learning Objectives
- Understand the diagnosis, progression and management of patients with Moderate to Severe Dry Eye Disease including being aware of an overview of current & new treatment options
- Know when moderate to Severe Dry Eye treatments are indicated and introduced within Dry Eye Disease patient journey
- Understand that one approach does not fit all in the management of these Moderate to Severe Dry eye disease patients, as we are dealing with very hypersensitive patients
- Understand the difference between Ocular medication Side Effects Vs Drug Formulation reactions of Patients with Dry Eye Disease
- Not forget the basics about Ocular Lubricants in combination with the Prescribed Interventions within the management of Moderate to Severe Dry Eye Disease Patients
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Diagnosis & Management of the Moderate-Severe Dry Eye Patient |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.5 |